Renaissance Technologies (RenTech)'s IMUX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 0 shares of Immunic, Inc. (IMUX) worth $0, representing 0.00% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in IMUX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 91,916 shares. Largest reduction occurred in Q2 2026, reducing 91,916 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Immunic (IMUX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunic (IMUX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -91,916 | Sold Out | 0 | $0.00 |
| Q1 2026 | +91,916 | New Buy | 91,916 | $11.10 |
| Q4 2025 | -39,165 | Sold Out | 0 | $0.00 |
| Q3 2025 | +25,950 | Add 196.37% | 39,165 | $8.82 |
| Q2 2025 | -53,731 | Reduce 80.26% | 13,215 | $6.98 |
| Q1 2025 | +10,284 | Add 18.15% | 66,946 | $10.90 |
| Q4 2024 | +17,754 | Add 45.63% | 56,662 | $10.00 |
| Q3 2024 | +9,799 | Add 33.66% | 38,908 | $16.50 |
| Q2 2024 | -45,618 | Reduce 61.05% | 29,109 | $11.10 |
| Q1 2024 | +67,246 | Add 898.89% | 74,727 | $13.19 |
| Q4 2023 | -50,259 | Reduce 87.04% | 7,481 | $14.97 |
| Q3 2023 | +42,250 | Add 272.76% | 57,740 | $14.70 |
| Q2 2023 | -22,256 | Reduce 58.96% | 15,490 | $0.03 |
| Q1 2023 | +37,746 | New Buy | 37,746 | $0.01 |
| Q4 2022 | -13,066 | Sold Out | 0 | $0.00 |
| Q3 2022 | +10,146 | Add 347.47% | 13,066 | $31.61 |
| Q2 2022 | +2,920 | New Buy | 2,920 | $34.59 |
| Q4 2021 | -1,670 | Sold Out | 0 | $0.00 |
| Q3 2021 | +1,670 | New Buy | 1,670 | $88.62 |
| Q1 2021 | -1,340 | Sold Out | 0 | $0.00 |
| Q4 2020 | -2,200 | Reduce 62.15% | 1,340 | $152.99 |
| Q3 2020 | -12,453 | Reduce 77.87% | 3,540 | $185.59 |
| Q2 2020 | +9,200 | Add 135.43% | 15,993 | $121.18 |
| Q1 2020 | +730 | Add 12.04% | 6,793 | $60.50 |
| Q4 2019 | +1,860 | Add 44.25% | 6,063 | $96.98 |
| Q3 2019 | +2,830 | Add 206.12% | 4,203 | $99.93 |
| Q2 2019 | +1,373 | New Buy | 1,373 | $114.35 |
Renaissance Technologies (RenTech)'s Immunic Investment FAQs
Renaissance Technologies (RenTech) first purchased Immunic, Inc. (IMUX) in Q2 2019, acquiring 1,373 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Immunic, Inc. (IMUX) for 27 quarters since Q2 2019.
Renaissance Technologies (RenTech)'s largest addition to Immunic, Inc. (IMUX) was in Q1 2026, adding 91,916 shares worth $1.02 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 0 shares of Immunic, Inc. (IMUX), valued at approximately $0.
As of the Q2 2026 filing, Immunic, Inc. (IMUX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Immunic, Inc. (IMUX) was 91,916 shares, as reported at the end of Q1 2026.